Tortoise Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-527
| Closed | -$29.3K | – | 1039 |
|
|
2025
Q3 | $29.3K | Buy |
527
+38
| +8% | +$2.22K | ﹤0.01% | 462 |
|
|
2025
Q2 | $33.8K | Hold |
489
| – | – | ﹤0.01% | 437 |
|
|
2025
Q1 | $34K | Hold |
489
| – | – | ﹤0.01% | 426 |
|
|
2024
Q4 | $42.1K | Hold |
489
| – | – | ﹤0.01% | 442 |
|
|
2024
Q3 | $58.2K | Hold |
489
| – | – | 0.01% | 385 |
|
|
2024
Q2 | $69.8K | Hold |
489
| – | – | 0.01% | 343 |
|
|
2024
Q1 | $62.8K | Buy |
489
+33
| +7% | +$3.93K | 0.01% | 356 |
|
|
2023
Q4 | $47.2K | Hold |
456
| – | – | 0.01% | 364 |
|
|
2023
Q3 | $41.5K | Hold |
456
| – | – | 0.01% | 363 |
|
|
2023
Q2 | $36.9K | Hold |
456
| – | – | 0.01% | 374 |
|
|
2023
Q1 | $36.3K | Hold |
456
| – | – | 0.01% | 369 |
|
|
2022
Q4 | $30.9K | Hold |
456
| – | – | 0.01% | 390 |
|
|
2022
Q3 | $23K | Hold |
456
| – | – | ﹤0.01% | 425 |
|
|
2022
Q2 | $25K | Hold |
456
| – | – | ﹤0.01% | 398 |
|
|
2022
Q1 | $25K | Hold |
456
| – | – | ﹤0.01% | 399 |
|
|
2021
Q4 | $26K | Hold |
456
| – | – | ﹤0.01% | 372 |
|
|
2021
Q3 | $22K | Hold |
456
| – | – | ﹤0.01% | 375 |
|
|
2021
Q2 | $19K | Hold |
456
| – | – | ﹤0.01% | 382 |
|
|
2021
Q1 | $15K | Hold |
456
| – | – | ﹤0.01% | 391 |
|
|
2020
Q4 | $16K | Hold |
456
| – | – | ﹤0.01% | 356 |
|
|
2020
Q3 | $16K | Hold |
456
| – | – | ﹤0.01% | 331 |
|
|
2020
Q2 | $15K | Hold |
456
| – | – | ﹤0.01% | 333 |
|
|
2020
Q1 | $14K | Hold |
456
| – | – | ﹤0.01% | 335 |
|
|
2019
Q4 | $13K | Hold |
456
| – | – | ﹤0.01% | 373 |
|
|
2019
Q3 | $12K | Hold |
456
| – | – | ﹤0.01% | 377 |
|
|
2019
Q2 | $12K | Hold |
456
| – | – | ﹤0.01% | 407 |
|
|
2019
Q1 | $12K | Hold |
456
| – | – | ﹤0.01% | 392 |
|
|
2018
Q4 | $11K | Hold |
456
| – | – | ﹤0.01% | 380 |
|
|
2018
Q3 | $11K | Buy |
456
+10
| +2% | +$244 | ﹤0.01% | 393 |
|
|
2018
Q2 | $10K | Hold |
446
| – | – | ﹤0.01% | 409 |
|
|
2018
Q1 | $11K | Hold |
446
| – | – | ﹤0.01% | 375 |
|
|
2017
Q4 | $12K | Hold |
446
| – | – | ﹤0.01% | 372 |
|
|
2017
Q3 | $11K | Hold |
446
| – | – | ﹤0.01% | 354 |
|
|
2017
Q2 | $10K | Buy |
446
+206
| +86% | +$4.16K | ﹤0.01% | 354 |
|
|
2017
Q1 | $4K | Hold |
240
| – | – | ﹤0.01% | 405 |
|
|
2016
Q4 | $4K | Hold |
240
| – | – | ﹤0.01% | 412 |
|
|
2016
Q3 | $5K | Hold |
240
| – | – | ﹤0.01% | 372 |
|
|
2016
Q2 | $6K | Hold |
240
| – | – | ﹤0.01% | 374 |
|
|
2016
Q1 | $7K | Buy |
+240
| New | +$6.43K | ﹤0.01% | 311 |
|
|
2015
Q3 | – | Sell |
-120
| Closed | -$3K | – | 428 |
|
|
2015
Q2 | $3K | Hold |
120
| – | – | ﹤0.01% | 390 |
|
|
2015
Q1 | $3K | Hold |
120
| – | – | ﹤0.01% | 370 |
|
|
2014
Q4 | $3K | Buy |
+120
| New | +$2.68K | ﹤0.01% | 397 |
|
|
2013
Q3 | – | Sell |
-710
| Closed | -$11K | – | 388 |
|
|
2013
Q2 | $11K | Buy |
+710
| New | +$11.8K | 0.01% | 221 |
|
Other funds holding NVO
F
Tortoise Investment Management's NVO Position: Q4 2025 in Review
Tortoise Investment Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 527 shares — an estimated $29.3K sold.
Tortoise Investment Management first reported a position in NVO in Q2 2013 and held it in 43 quarters. The position peaked at $69.8K in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- Tortoise Investment Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- Tortoise Investment Management sold 527 Novo Nordisk shares in Q4 2025, an estimated $29.3K.
- Tortoise Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 43 quarters.
- Tortoise Investment Management's Novo Nordisk position peaked at $69.8K in Q2 2024.
- 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.